Showing results (201-210 of 291) with videos related to

Sort By:
Pageof 30
Blood Advances|September 22, 2023
Low rate of nonrelapse mortality in under-4-year-olds with ALL given chemotherapeutic conditioning for HSCT: a phase 3 FORUM studyPeter Bader, Ulrike Pötschger, Jean-Hugues Dalle, et al.
Leukemia|October 31, 2022
Outcome of chimeric antigen receptor T-cell therapy following treatment with inotuzumab ozogamicin in children with relapsed or refractory acute lymphoblastic leukemiaValeria Ceolin, Erica Brivio, Harm van Tinteren, et al.
Frontiers in Oncology|May 27, 2022
No Improvement of Survival for Alveolar Rhabdomyosarcoma Patients After HLA-Matched Versus -Mismatched Allogeneic Hematopoietic Stem Cell Transplantation Compared to Standard-of-Care TherapySebastian Johannes Schober, Erika Hallmen, Florian Reßle, et al.
Bone Marrow Transplantation|September 28, 2018
AlloHSCT in paediatric ALL and AML in complete remission: improvement over time impacted by accreditation?Shahrzad Bakhtiar, Emilia Salzmann-Manrique, Martin Hutter, et al.
Journal of Hematology & Oncology|January 17, 2025
Multinational retrospective analysis of bridging therapy prior to chimeric antigen receptor t cells for relapsed/refractory acute lymphoblastic leukemia in children and young adultsMaike Breidenbach, Peter Bader, Andishe Attarbaschi, et al.
Haematologica|February 15, 2024
Approaches for bridging therapy prior to chimeric antigen receptor T cells for relapsed/refractory acute lymphoblastic B-lineage leukemia in children and young adultsTobias Feuchtinger, Peter Bader, Marion Subklewe, et al.
Leukemia|April 26, 2022
CD19 CAR T-cells for pediatric relapsed acute lymphoblastic leukemia with active CNS involvement: a retrospective international studyElad Jacoby, Sara Ghorashian, Britta Vormoor, et al.
Cancers|January 11, 2025
Long-Term Outcomes and Quality of Life of High-Risk Neuroblastoma Patients Treated with a Multimodal Treatment Including Anti-GD2 Immunotherapy: A Retrospective Cohort StudyTim Flaadt, Jonas Rehm, Thorsten Simon, et al.
Frontiers in Oncology|June 5, 2013
Clinical grade purification and expansion of NK cell products for an optimized manufacturing protocolUlrike Koehl, Claudia Brehm, Sabine Huenecke, et al.
Bone Marrow Transplantation|September 27, 2019
Autoimmune cytopenias (AIC) following allogeneic haematopoietic stem cell transplant for acquired aplastic anaemia: a joint study of the Autoimmune Diseases and Severe Aplastic Anaemia Working Parties (ADWP/SAAWP) of the European Society for Blood and Marrow Transplantation (EBMT)Paul D E Miller, John A Snowden, Regis Peffault De Latour, et al.
Pageof 30